Stay updated on Efficacy of Dupilumab in EoE Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Dupilumab in EoE Clinical Trial page.

Latest updates to the Efficacy of Dupilumab in EoE Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link instead of the study record content. This indicates an access/permissions issue that blocks viewing the study details.SummaryDifference20%

- Check21 days agoChange DetectedRevision label on the page updated to v3.7.0, replacing the previous v3.6.6.SummaryDifference0.0%

- Check35 days agoChange DetectedA new bibliographic citation for a Dupilumab-related publication in eosinophilic esophagitis was added. The page revision number was updated from v3.6.5 to v3.6.6 to reflect the latest version.SummaryDifference0.1%

- Check42 days agoChange DetectedA funding attribution line for NIH grant/contract was added to the page, indicating NIH support for the study.SummaryDifference0.0%

- Check56 days agoChange DetectedA new 2026 publication by Lim et al. about dupilumab normalizing the eosinophilic esophagitis transcriptome was added to the publications list, and a prior online-ahead-of-print citation for the same work was deleted, reflecting an update to the study's referenced literature.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded a new publication citation for a 2026 Dupilumab pharmacokinetics study in EoE, and updated the page revision from v3.6.3 to v3.6.4.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Dupilumab in EoE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Dupilumab in EoE Clinical Trial page.